PE/Cyanine5 Streptavidin
Streptavidin binds to biotin with high affinity. Streptavidin-PE/Cyanine5 is useful for detecting biotinylated antibodies. The excitation of PE/Cyanine5 by 488 nm laser light induces a light emission maximum of 670 nm.
PRODUCT DETAILS
Clone: None
Antibody Type: None
Reactivity: Human, Mouse, Rat, All Species
Format: PE-Cyanine5
Host:
Isotype: None
Applications: FC - Quality tested ICFC - Verified
Regulatory Status: RUO
Note to Purchaser: This product is manufactured and supplied by BioLegend, Inc. under an agreement between BioLegend, Inc. and Cytek Biosciences, Inc. Information related to this product is provided by BioLegend, Inc.
PE/Cyanine5 Streptavidin
Streptavidin binds to biotin with high affinity. Streptavidin-PE/Cyanine5 is useful for detecting biotinylated antibodies. The excitation of PE/Cyanine5 by 488 nm laser light induces a light emission maximum of 670 nm.
PRODUCT DETAILS
Clone: None
Antibody Type: None
Reactivity: Human, Mouse, Rat, All Species
Format: PE-Cyanine5
Host:
Isotype: None
Applications: FC - Quality tested ICFC - Verified
Regulatory Status: RUO
Note to Purchaser: This product is manufactured and supplied by BioLegend, Inc. under an agreement between BioLegend, Inc. and Cytek Biosciences, Inc. Information related to this product is provided by BioLegend, Inc.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Streptavidin binds to biotin with high affinity. Streptavidin-PE/Cyanine5 is useful for detecting biotinylated antibodies. The excitation of PE/Cyanine5 by 488 nm laser light induces a light emission maximum of 670 nm.
PRODUCT DETAILS
Clone: None
Antibody Type: None
Reactivity: Human, Mouse, Rat, All Species
Format: PE-Cyanine5
Host:
Isotype: None
Applications: FC - Quality tested ICFC - Verified
Regulatory Status: RUO
Note to Purchaser: This product is manufactured and supplied by BioLegend, Inc. under an agreement between BioLegend, Inc. and Cytek Biosciences, Inc. Information related to this product is provided by BioLegend, Inc.
